The American College of Cardiology (ACC) has recognized NewYork-Presbyterian Lawrence Hospital for its demonstrated expertise and commitment in treating patients with chest pain.

Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.

Weill Cornell Medicine has received complementary grants from Genentech and the Leukemia & Lymphoma Society (LLS) to support a new program that aims to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.

Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies through umbilical cord blood to their babies.

Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially-resolved tissue mapping tools were created by a multidisciplinary team of Weill Cornell Medicine and NewYork-Presbyterian Hospital-led researchers and used to map SARS-CoV-2 infections at the height of the initial COVID-19 outbreak in New York City.

Researchers at the Columbia University Fertility Center have developed a rapid and accurate one-step diagnostic test that detects SARS-CoV-2, the virus that causes COVID-19, in samples of saliva.

Today, NewYork-Presbyterian Brooklyn Methodist Hospital celebrated the opening of the Center for Community Health. The Center for Community Health is a world-class ambulatory care center where leading specialists, working collaboratively under one roof, combine innovative clinical approaches and cutting-edge technology to provide exceptional, comprehensive care to the Brooklyn community.

Pulmonologists at NewYork-Presbyterian/Weill Cornell Medical Center are developing a new paradigm to confront idiopathic pulmonary fibrosis (IPF) and other forms of progressive fibrotic ILDs.